| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 16/08/2024 |
| azithromycin dihydrate | Tablet, film coated | 524.05 mg | Anticipated | Available | Manufacturing | 16/08/2024 |
| hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil | Tablet | 25 mg~6.944 mg~40 mg | Current | Unavailable | Manufacturing | 16/08/2024 |
| latanoprost | Eye Drops, solution | 50 microgram/mL | Resolved | Available | Unexpected increase in consumer demand | 16/08/2024 |
| acarbose | Tablet | 50 mg | Current | Unavailable | Manufacturing | 16/08/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 16/08/2024 |
| cefuroxime axetil | Tablet, film coated | 300.715 mg | Resolved | Available | Unexpected increase in consumer demand | 16/08/2024 |
| paracetamol | Injection | 1 g | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 16/08/2024 |
| dosulepin (dothiepin) hydrochloride | Capsule, hard | 25 mg | Current | Limited Availability | Manufacturing | 16/08/2024 |
| bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate | Injection, solution | 2.64 mg/mL~4.5 microgram/mL | Resolved | Available | Manufacturing | 16/08/2024 |
| cinacalcet hydrochloride | Tablet, film coated | 33 mg | Current | Limited Availability | Manufacturing | 16/08/2024 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 16/08/2024 |
| erythromycin ethyl succinate | Oral Liquid, powder for | 468 mg | Anticipated | Available | Unexpected increase in consumer demand | 16/08/2024 |
| doxorubicin hydrochloride | Injection, concentrated | 2 mg/mL | Resolved | Available | Manufacturing | 16/08/2024 |
| clindamycin phosphate | Lotion | 10 mg/mL | Anticipated | Available | Manufacturing | 16/08/2024 |
| pamidronate disodium | Injection, concentrated | 9 mg | Current | Limited Availability | Manufacturing | 16/08/2024 |
| ezetimibe | Tablet | 10 mg | Resolved | Available | Unexpected increase in consumer demand | 16/08/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Current | Limited Availability | Manufacturing | 16/08/2024 |
| povidoneiodine | Application | 100 mg/mL | Current | Limited Availability | Manufacturing | 15/08/2024 |
| risperidone | Tablet, film coated | 4 mg | Anticipated | Available | Manufacturing | 15/08/2024 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 15/08/2024 |
| tacrolimus monohydrate | Capsule, hard | 1.022 mg | Anticipated | Available | Manufacturing | 15/08/2024 |
| valaciclovir hydrochloride monohydrate | Tablet, film coated | 611.7 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 15/08/2024 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Limited Availability | Manufacturing | 15/08/2024 |
| enalapril maleate | Tablet | 10 mg | Resolved | Available | Manufacturing | 15/08/2024 |
| quetiapine fumarate | Tablet, film coated | 345.36 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| temozolomide | Capsule, hard | 5 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| temozolomide | Capsule, hard | 180 mg | Resolved | Available | Manufacturing | 15/08/2024 |
| rosuvastatin calcium | Tablet, film coated | 5.21 mg | Resolved | Available | Manufacturing | 15/08/2024 |
| olmesartan medoxomil | Tablet | 40 mg | Resolved | Available | Manufacturing | 15/08/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 15/08/2024 |
| irbesartan | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 15/08/2024 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 25 mg~300 mg | Anticipated | Available | Manufacturing | 15/08/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 15/08/2024 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 25 mg~40 mg | Resolved | Available | Manufacturing | 15/08/2024 |
| flecainide acetate | Tablet | 50 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| dasatinib | Tablet, film coated | 100 mg | Current | Limited Availability | Manufacturing | 15/08/2024 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 15/08/2024 |
| lacosamide | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 15/08/2024 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| estradiol | Drug delivery system, transdermal | .585 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| estradiol | Drug delivery system, transdermal | 1.56 mg | Current | Unavailable | Manufacturing | 15/08/2024 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 41.6 mg~10 mg | Current | Limited Availability | Manufacturing | 15/08/2024 |
| lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate | Injection, solution | 5 mg/mL~9.1 microgram/mL | Discontinued | Unavailable | Manufacturing | 14/08/2024 |
| adrenaline (epinephrine) | Injection, solution | 1 mg | Current | Limited Availability | Manufacturing | 14/08/2024 |
| anidulafungin | Injection, powder for | 100 mg | Anticipated | Available | Manufacturing | 14/08/2024 |
| adrenaline (epinephrine) | Injection, solution | 1 mg | Current | Limited Availability | Manufacturing | 14/08/2024 |
| efmoroctocog alfa | Injection, powder for | 250 IU | Current | Unavailable | Manufacturing | 14/08/2024 |
| Insulin aspart | Injection, solution | 100 U/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 14/08/2024 |
| cinacalcet hydrochloride | Tablet, film coated | 66 mg | Resolved | Available | Manufacturing | 14/08/2024 |
| cinacalcet hydrochloride | Tablet, film coated | 99 mg | Resolved | Available | Manufacturing | 14/08/2024 |
| ezetimibe | Tablet | 10 mg | Current | Unavailable | Manufacturing | 14/08/2024 |
| nizatidine | Capsule, hard | 300 mg | Current | Unavailable | Manufacturing | 14/08/2024 |
| Coxiella burnetii | Injection | 5 microgram/mL | Current | Limited Availability | Manufacturing | 13/08/2024 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/08/2024 |
| eprosartan mesilate~hydrochlorothiazide | Tablet, film coated | 735.8 mg~12.5 mg | Discontinued | Unavailable | Manufacturing | 13/08/2024 |
| insulin | Injection, solution | 100 IU/mL | Resolved | Available | Manufacturing | 13/08/2024 |
| griseofulvin | Tablet | 500 mg | Current | Unavailable | Manufacturing | 13/08/2024 |
| papaverine hydrochloride | Injection, solution | 12 mg/mL | Anticipated | Available | Manufacturing | 13/08/2024 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Anticipated | Available | Manufacturing | 13/08/2024 |
| ropivacaine hydrochloride | Injection, solution | 400 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 13/08/2024 |
| olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate | Tablet | 40 mg~12.5 mg~6.944 mg | Resolved | Available | Manufacturing | 13/08/2024 |
| capecitabine | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 13/08/2024 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 182 microgram/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 13/08/2024 |
| codeine phosphate hemihydrate~doxylamine succinate~paracetamol | Tablet, uncoated | 10 mg~5.1 mg~500 mg | Current | Unavailable | Manufacturing | 13/08/2024 |
| bosentan monohydrate | Tablet, film coated | 64.541 mg | Current | Unavailable | Manufacturing | 13/08/2024 |
| ezetimibe | Tablet | 10 mg | Current | Unavailable | Manufacturing | 13/08/2024 |
| cisplatin | Injection, concentrated | 1 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 13/08/2024 |
| cisplatin | Injection, concentrated | 1 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 13/08/2024 |
| dasatinib | Tablet, film coated | 70 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 13/08/2024 |
| mercaptopurine monohydrate | Tablet | 50 mg | Resolved | Available | Manufacturing | 13/08/2024 |
| gefitinib | Tablet, film coated | 250 mg | Current | Unavailable | Product recall | 13/08/2024 |
| iopromide | Injection, solution | 768.86 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 13/08/2024 |
| tamsulosin hydrochloride~dutasteride | Capsule, modified release | 400 microgram~500 microgram | Resolved | Available | Manufacturing | 13/08/2024 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Limited Availability | Manufacturing | 13/08/2024 |
| lanreotide acetate | Injection, solution | 133.33 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 13/08/2024 |
| dasatinib | Tablet, film coated | 50 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 13/08/2024 |
| tirzepatide | Injection, solution | 5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/08/2024 |
| tirzepatide | Injection, solution | 7.5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/08/2024 |
| tirzepatide | Injection, solution | 12.5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/08/2024 |
| tirzepatide | Injection, solution | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/08/2024 |
| tirzepatide | Injection, solution | 15 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/08/2024 |
| tirzepatide | Injection, solution | 2.5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/08/2024 |
| fluticasone propionate | Inhalation, pressurised | 125 microgram/actuation | Anticipated | Available | Unexpected increase in consumer demand | 13/08/2024 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 13/08/2024 |
| tobramycin | Injection, solution | 80 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 12/08/2024 |
| fentanyl | Drug delivery system, transdermal | 7.65 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 12/08/2024 |
| fentanyl | Drug delivery system, transdermal | 1.28 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 12/08/2024 |
| perindopril erbumine | Tablet | 8 mg | Current | Limited Availability | Manufacturing | 12/08/2024 |
| betahistine dihydrochloride | Tablet, uncoated | 16 mg | Discontinued | Unavailable | Manufacturing | 12/08/2024 |
| clopidogrel hydrogen sulfate~aspirin | Tablet | 97.87 mg~100 mg | Current | Limited Availability | Manufacturing | 12/08/2024 |
| Bevacizumab | Injection, concentrated | 25 mg/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 12/08/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 26.22 mg/mL | Current | Unavailable | Manufacturing | 12/08/2024 |
| bortezomib | Injection, solution | 3.5 mg | Current | Unavailable | Manufacturing | 12/08/2024 |
| fentanyl citrate | Injection, solution | 157 microgram | Current | Limited Availability | Manufacturing | 12/08/2024 |
| eprosartan mesilate | Tablet, film coated | 400 mg | Discontinued | Unavailable | Manufacturing | 12/08/2024 |
| doxycycline monohydrate | Tablet, uncoated | 104.1 mg | Resolved | Available | Manufacturing | 12/08/2024 |
| heparin sodium | Injection, solution | 10 IU/mL | Anticipated | Available | Manufacturing | 12/08/2024 |
| ketamine hydrochloride | Injection, solution | 115.3 mg/mL | Resolved | Available | Manufacturing | 12/08/2024 |
| norethisterone acetate~estradiol | Drug delivery system, transdermal | 2.7 mg~.62 mg | Resolved | Available | Manufacturing | 12/08/2024 |
2024年8月20日